International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

International Nosocomial Infection Control consortium Members

Research output: Contribution to journalArticle

140 Citations (Scopus)

Abstract

We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care-associated infection (DA-HAI), we collected prospective data from 605,310 patients hospitalized in the INICC's ICUs for an aggregate of 3,338,396 days. Although device utilization in the INICC's ICUs was similar to that reported from ICUs in the U.S. in the CDC's NHSN, rates of device-associated nosocomial infection were higher in the ICUs of the INICC hospitals: the pooled rate of central line-associated bloodstream infection in the INICC's ICUs, 4.9 per 1,000 central line days, is nearly 5-fold higher than the 0.9 per 1,000 central line days reported from comparable U.S. ICUs. The overall rate of ventilator-associated pneumonia was also higher (16.8 vs 1.1 per 1,000 ventilator days) as was the rate of catheter-associated urinary tract infection (5.5 vs 1.3 per 1,000 catheter days). Frequencies of resistance of Pseudomonas isolates to amikacin (42.8% vs 10%) and imipenem (42.4% vs 26.1%) and Klebsiella pneumoniae isolates to ceftazidime (71.2% vs 28.8%) and imipenem (19.6% vs 12.8%) were also higher in the INICC's ICUs compared with the ICUs of the CDC's NHSN.

Original languageEnglish (US)
Pages (from-to)942-956
Number of pages15
JournalAmerican Journal of Infection Control
Volume42
Issue number9
DOIs
StatePublished - Sep 1 2014

Fingerprint

Infection Control
Cross Infection
Intensive Care Units
Equipment and Supplies
Centers for Disease Control and Prevention (U.S.)
Imipenem
Delivery of Health Care
Safety
Ventilator-Associated Pneumonia
Catheter-Related Infections
Ceftazidime
Amikacin
Latin America
Klebsiella pneumoniae
Mechanical Ventilators
Pseudomonas
Urinary Tract Infections
Catheters
Infection

Keywords

  • Antibiotic resistance
  • Bloodstream infection
  • Catheter-associated urinary tract infection
  • Central line-associated bloodstream infections
  • Developing countries
  • Device-associated infection
  • Health care-associated infection
  • Hospital infection
  • Limited resources countries
  • Low income countries
  • Network
  • Nosocomial infection
  • Urinary tract infection
  • Ventilator-associated pneumonia

ASJC Scopus subject areas

  • Epidemiology
  • Health Policy
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module. / International Nosocomial Infection Control consortium Members.

In: American Journal of Infection Control, Vol. 42, No. 9, 01.09.2014, p. 942-956.

Research output: Contribution to journalArticle

@article{824d85853c2749bd99c774090d871c8f,
title = "International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module",
abstract = "We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care-associated infection (DA-HAI), we collected prospective data from 605,310 patients hospitalized in the INICC's ICUs for an aggregate of 3,338,396 days. Although device utilization in the INICC's ICUs was similar to that reported from ICUs in the U.S. in the CDC's NHSN, rates of device-associated nosocomial infection were higher in the ICUs of the INICC hospitals: the pooled rate of central line-associated bloodstream infection in the INICC's ICUs, 4.9 per 1,000 central line days, is nearly 5-fold higher than the 0.9 per 1,000 central line days reported from comparable U.S. ICUs. The overall rate of ventilator-associated pneumonia was also higher (16.8 vs 1.1 per 1,000 ventilator days) as was the rate of catheter-associated urinary tract infection (5.5 vs 1.3 per 1,000 catheter days). Frequencies of resistance of Pseudomonas isolates to amikacin (42.8{\%} vs 10{\%}) and imipenem (42.4{\%} vs 26.1{\%}) and Klebsiella pneumoniae isolates to ceftazidime (71.2{\%} vs 28.8{\%}) and imipenem (19.6{\%} vs 12.8{\%}) were also higher in the INICC's ICUs compared with the ICUs of the CDC's NHSN.",
keywords = "Antibiotic resistance, Bloodstream infection, Catheter-associated urinary tract infection, Central line-associated bloodstream infections, Developing countries, Device-associated infection, Health care-associated infection, Hospital infection, Limited resources countries, Low income countries, Network, Nosocomial infection, Urinary tract infection, Ventilator-associated pneumonia",
author = "{International Nosocomial Infection Control consortium Members} and Rosenthal, {V{\'i}ctor Daniel} and Maki, {Dennis George} and Yatin Mehta and Hakan Leblebicioglu and Memish, {Ziad Ahmed} and Al-Mousa, {Haifaa Hassan} and Hanan Balkhy and Bijie Hu and Carlos Alvarez-Moreno and Medeiros, {Eduardo Alexandrino} and Anucha Apisarnthanarak and Lul Raka and Cuellar, {Luis E.} and Altaf Ahmed and Navoa-Ng, {Josephine Anne} and El-Kholy, {Amani Ali} and Kanj, {Souha Sami} and Ider Bat-Erdene and Wieslawa Duszynska and {Van Truong}, Nguyen and Pazmino, {Leonardo N.} and See-Lum, {Lucy Chai} and Rosalia Fern{\'a}ndez-Hidalgo and Gabriela Di-Silvestre and Farid Zand and Sona Hlinkova and Vladislav Belskiy and Hussain Al-Rahma and Luque-Torres, {Marco Tulio} and Nesil Bayraktar and Zan Mitrev and Vaidotas Gurskis and Dale Fisher and Abu-Khader, {Ilham Bulos} and Kamal Berechid and Arnaldo Rodr{\'i}guez-S{\'a}nchez and Horhat, {Florin George} and Osiel Requejo-Pino and Nassya Hadjieva and Nejla Ben-Jaballah and El{\'i}as Garc{\'i}a-Mayorca and Luis Kushner-D{\'a}valos and Srdjan Pasic and Pedrozo-Ortiz, {Luis E.} and Eleni Apostolopoulou and Nepomuceno Mej{\'i}a and Gamar-Elanbya, {May Osman} and Kushlani Jayatilleke and {De Lourdes-Due{\~n}as}, Miriam and Mendez, {Julio C}",
year = "2014",
month = "9",
day = "1",
doi = "10.1016/j.ajic.2014.05.029",
language = "English (US)",
volume = "42",
pages = "942--956",
journal = "American Journal of Infection Control",
issn = "0196-6553",
publisher = "Mosby Inc.",
number = "9",

}

TY - JOUR

T1 - International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

AU - International Nosocomial Infection Control consortium Members

AU - Rosenthal, Víctor Daniel

AU - Maki, Dennis George

AU - Mehta, Yatin

AU - Leblebicioglu, Hakan

AU - Memish, Ziad Ahmed

AU - Al-Mousa, Haifaa Hassan

AU - Balkhy, Hanan

AU - Hu, Bijie

AU - Alvarez-Moreno, Carlos

AU - Medeiros, Eduardo Alexandrino

AU - Apisarnthanarak, Anucha

AU - Raka, Lul

AU - Cuellar, Luis E.

AU - Ahmed, Altaf

AU - Navoa-Ng, Josephine Anne

AU - El-Kholy, Amani Ali

AU - Kanj, Souha Sami

AU - Bat-Erdene, Ider

AU - Duszynska, Wieslawa

AU - Van Truong, Nguyen

AU - Pazmino, Leonardo N.

AU - See-Lum, Lucy Chai

AU - Fernández-Hidalgo, Rosalia

AU - Di-Silvestre, Gabriela

AU - Zand, Farid

AU - Hlinkova, Sona

AU - Belskiy, Vladislav

AU - Al-Rahma, Hussain

AU - Luque-Torres, Marco Tulio

AU - Bayraktar, Nesil

AU - Mitrev, Zan

AU - Gurskis, Vaidotas

AU - Fisher, Dale

AU - Abu-Khader, Ilham Bulos

AU - Berechid, Kamal

AU - Rodríguez-Sánchez, Arnaldo

AU - Horhat, Florin George

AU - Requejo-Pino, Osiel

AU - Hadjieva, Nassya

AU - Ben-Jaballah, Nejla

AU - García-Mayorca, Elías

AU - Kushner-Dávalos, Luis

AU - Pasic, Srdjan

AU - Pedrozo-Ortiz, Luis E.

AU - Apostolopoulou, Eleni

AU - Mejía, Nepomuceno

AU - Gamar-Elanbya, May Osman

AU - Jayatilleke, Kushlani

AU - De Lourdes-Dueñas, Miriam

AU - Mendez, Julio C

PY - 2014/9/1

Y1 - 2014/9/1

N2 - We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care-associated infection (DA-HAI), we collected prospective data from 605,310 patients hospitalized in the INICC's ICUs for an aggregate of 3,338,396 days. Although device utilization in the INICC's ICUs was similar to that reported from ICUs in the U.S. in the CDC's NHSN, rates of device-associated nosocomial infection were higher in the ICUs of the INICC hospitals: the pooled rate of central line-associated bloodstream infection in the INICC's ICUs, 4.9 per 1,000 central line days, is nearly 5-fold higher than the 0.9 per 1,000 central line days reported from comparable U.S. ICUs. The overall rate of ventilator-associated pneumonia was also higher (16.8 vs 1.1 per 1,000 ventilator days) as was the rate of catheter-associated urinary tract infection (5.5 vs 1.3 per 1,000 catheter days). Frequencies of resistance of Pseudomonas isolates to amikacin (42.8% vs 10%) and imipenem (42.4% vs 26.1%) and Klebsiella pneumoniae isolates to ceftazidime (71.2% vs 28.8%) and imipenem (19.6% vs 12.8%) were also higher in the INICC's ICUs compared with the ICUs of the CDC's NHSN.

AB - We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care-associated infection (DA-HAI), we collected prospective data from 605,310 patients hospitalized in the INICC's ICUs for an aggregate of 3,338,396 days. Although device utilization in the INICC's ICUs was similar to that reported from ICUs in the U.S. in the CDC's NHSN, rates of device-associated nosocomial infection were higher in the ICUs of the INICC hospitals: the pooled rate of central line-associated bloodstream infection in the INICC's ICUs, 4.9 per 1,000 central line days, is nearly 5-fold higher than the 0.9 per 1,000 central line days reported from comparable U.S. ICUs. The overall rate of ventilator-associated pneumonia was also higher (16.8 vs 1.1 per 1,000 ventilator days) as was the rate of catheter-associated urinary tract infection (5.5 vs 1.3 per 1,000 catheter days). Frequencies of resistance of Pseudomonas isolates to amikacin (42.8% vs 10%) and imipenem (42.4% vs 26.1%) and Klebsiella pneumoniae isolates to ceftazidime (71.2% vs 28.8%) and imipenem (19.6% vs 12.8%) were also higher in the INICC's ICUs compared with the ICUs of the CDC's NHSN.

KW - Antibiotic resistance

KW - Bloodstream infection

KW - Catheter-associated urinary tract infection

KW - Central line-associated bloodstream infections

KW - Developing countries

KW - Device-associated infection

KW - Health care-associated infection

KW - Hospital infection

KW - Limited resources countries

KW - Low income countries

KW - Network

KW - Nosocomial infection

KW - Urinary tract infection

KW - Ventilator-associated pneumonia

UR - http://www.scopus.com/inward/record.url?scp=84906828768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906828768&partnerID=8YFLogxK

U2 - 10.1016/j.ajic.2014.05.029

DO - 10.1016/j.ajic.2014.05.029

M3 - Article

C2 - 25179325

AN - SCOPUS:84906828768

VL - 42

SP - 942

EP - 956

JO - American Journal of Infection Control

JF - American Journal of Infection Control

SN - 0196-6553

IS - 9

ER -